Temasek Participates in Series B Round in Homology Medicines

Sovereign wealth capital keeps on targeting gene editing companies. Gene editing could have major implications on global health. China has been very aggressive in the field of gene editing in recent years.

[ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute

institutional investor investment mandates